메뉴 건너뛰기




Volumn 27, Issue 9, 2013, Pages 531-539

Challenges in the diagnosis and management of autoimmune hepatitis

Author keywords

Autoimmune; Challenges; Interventions; Nonstandard drugs; Phenotypes

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UNCLASSIFIED DRUG;

EID: 84884373386     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/981086     Document Type: Review
Times cited : (24)

References (100)
  • 1
    • 19944429145 scopus 로고    scopus 로고
    • Treatment challenges and investigational opportunities in autoimmune hepatitis
    • Czaja AJ, Bianchi FB, Carpenter HA, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005;41:207-15.
    • (2005) Hepatology , vol.41 , pp. 207-215
    • Czaja, A.J.1    Bianchi, F.B.2    Carpenter, H.A.3
  • 2
    • 77649253794 scopus 로고    scopus 로고
    • Difficult treatment decisions in autoimmune hepatitis
    • Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010;16:934-47.
    • (2010) World J Gastroenterol , vol.16 , pp. 934-947
    • Czaja, A.J.1
  • 3
    • 77957893679 scopus 로고    scopus 로고
    • Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis
    • Czaja AJ. Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis. Dig Dis Sci 2010;55:2712-26.
    • (2010) Dig Dis Sci , vol.55 , pp. 2712-2726
    • Czaja, A.J.1
  • 4
    • 29444453466 scopus 로고    scopus 로고
    • Diverse manifestations and evolving treatments of autoimmune hepatitis
    • Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol Dietol 2005;51:313-33.
    • (2005) Minerva Gastroenterol Dietol , vol.51 , pp. 313-333
    • Czaja, A.J.1
  • 5
    • 67651241981 scopus 로고    scopus 로고
    • Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment
    • Czaja AJ, Bayraktar Y. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World J Gastroenterol 2009;15:2314-28.
    • (2009) World J Gastroenterol , vol.15 , pp. 2314-2328
    • Czaja, A.J.1    Bayraktar, Y.2
  • 6
    • 84877250391 scopus 로고    scopus 로고
    • Autoimmune hepatitis in diverse ethnic populations and geographical regions
    • Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol 2013;7:365-85.
    • (2013) Expert Rev Gastroenterol Hepatol , vol.7 , pp. 365-385
    • Czaja, A.J.1
  • 7
    • 77953889134 scopus 로고    scopus 로고
    • Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis
    • Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis. Gastroenterology 2010;139:58-72.
    • (2010) Gastroenterology , vol.139 , pp. 58-72
    • Czaja, A.J.1    Manns, M.P.2
  • 8
    • 84866391821 scopus 로고    scopus 로고
    • Advances in the current treatment of autoimmune hepatitis
    • Czaja AJ. Advances in the current treatment of autoimmune hepatitis. Dig Dis Sci 2012;57:1996-2010.
    • (2012) Dig Dis Sci , vol.5757 , pp. 1996-2010
    • Czaja, A.J.1
  • 9
    • 41149153531 scopus 로고    scopus 로고
    • Autoimmune hepatitis. Part A: Pathogenesis
    • Czaja AJ. Autoimmune hepatitis. Part A: Pathogenesis. Expert Rev Gastroenterol Hepatol 2007;1:113-28.
    • (2007) Expert Rev Gastroenterol Hepatol , vol.1 , pp. 113-128
    • Czaja, A.J.1
  • 10
    • 41149179971 scopus 로고    scopus 로고
    • Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis
    • Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008;6:379-88.
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 379-388
    • Czaja, A.J.1
  • 12
    • 80055088856 scopus 로고    scopus 로고
    • Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis
    • Czaja AJ. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis. Curr Pharm Des 2011;17:3120-40.
    • (2011) Curr Pharm des , vol.17 , pp. 3120-3140
    • Czaja, A.J.1
  • 13
    • 84866397703 scopus 로고    scopus 로고
    • Nonstandard drugs and feasible new interventions for autoimmune hepatitis. Part i
    • Czaja AJ. Nonstandard drugs and feasible new interventions for autoimmune hepatitis. Part I. Inflamm Allergy Drug Targets 2012;11:337-50.
    • (2012) Inflamm Allergy Drug Targets , vol.11 , pp. 337-350
    • Czaja, A.J.1
  • 14
    • 84867739910 scopus 로고    scopus 로고
    • Nonstandard drugs and feasible new interventions for autoimmune hepatitis. Part II
    • Czaja AJ. Nonstandard drugs and feasible new interventions for autoimmune hepatitis. Part II. Inflamm Allergy Drug Targets 2012;11:351-63.
    • (2012) Inflamm Allergy Drug Targets , vol.11 , pp. 351-363
    • Czaja, A.J.1
  • 15
    • 84866770664 scopus 로고    scopus 로고
    • Autoimmune hepatitis: Focusing on treatments other than steroids
    • Czaja AJ. Autoimmune hepatitis: Focusing on treatments other than steroids. Can J Gastroenterol 2012;26:615-20.
    • (2012) Can J Gastroenterol , vol.26 , pp. 615-620
    • Czaja, A.J.1
  • 16
    • 84876691081 scopus 로고    scopus 로고
    • Acute and acute severe (fulminant) autoimmune hepatitis
    • Czaja AJ. Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci 2013;58:897-914.
    • (2013) Dig Dis Sci , vol.58 , pp. 897-914
    • Czaja, A.J.1
  • 17
    • 0036083869 scopus 로고    scopus 로고
    • Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: A study of 68 patients
    • Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: A study of 68 patients. J Clin Gastroenterol 2002;35:75-81.
    • (2002) J Clin Gastroenterol , vol.35 , pp. 75-81
    • Kogan, J.1    Safadi, R.2    Ashur, Y.3    Shouval, D.4    Ilan, Y.5
  • 18
    • 21344453508 scopus 로고    scopus 로고
    • Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
    • Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005;42:53-62.
    • (2005) Hepatology , vol.42 , pp. 53-62
    • Feld, J.J.1    Dinh, H.2    Arenovich, T.3
  • 20
    • 0038748278 scopus 로고    scopus 로고
    • Clinicopathological features of acute-onset autoimmune hepatitis
    • Okano N, Yamamoto K, Sakaguchi K, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res 2003;25:263-70.
    • (2003) Hepatol Res , vol.25 , pp. 263-270
    • Okano, N.1    Yamamoto, K.2    Sakaguchi, K.3
  • 21
    • 3042535422 scopus 로고    scopus 로고
    • Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis
    • Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004;2:625-31.
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 625-631
    • Kessler, W.R.1    Cummings, O.W.2    Eckert, G.3
  • 23
    • 34548165103 scopus 로고    scopus 로고
    • Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis
    • Miyake Y, Iwasaki Y, Terada R, et al. Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis. Hepatol Res 2007;37:801-5.
    • (2007) Hepatol Res , vol.37 , pp. 801-805
    • Miyake, Y.1    Iwasaki, Y.2    Terada, R.3
  • 24
    • 0034807020 scopus 로고    scopus 로고
    • Autoimmune hepatitis with incidental histologic features of bile duct injury
    • Czaja AJ, Carpenter HA. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001;34:659-65.
    • (2001) Hepatology , vol.34 , pp. 659-665
    • Czaja, A.J.1    Carpenter, H.A.2
  • 25
    • 4444319614 scopus 로고    scopus 로고
    • Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis
    • Czaja AJ, Muratori P, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 2004;24:322-9.
    • (2004) Liver Int , vol.24 , pp. 322-329
    • Czaja, A.J.1    Muratori, P.2    Muratori, L.3    Carpenter, H.A.4    Bianchi, F.B.5
  • 26
    • 0032718310 scopus 로고    scopus 로고
    • International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
    • Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
    • (1999) J Hepatol , vol.31 , pp. 929-938
    • Alvarez, F.1    Berg, P.A.2    Bianchi, F.B.3
  • 27
    • 47149112922 scopus 로고    scopus 로고
    • Simplified criteria for the diagnosis of autoimmune hepatitis
    • Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76.
    • (2008) Hepatology , vol.48 , pp. 169-176
    • Hennes, E.M.1    Zeniya, M.2    Czaja, A.J.3
  • 28
    • 3242757530 scopus 로고    scopus 로고
    • Type 1 autoimmune hepatitis: Patterns of clinical presentation and differential diagnosis of the 'acute' type
    • Ferrari R, Pappas G, Agostinelli D, et al. Type 1 autoimmune hepatitis: Patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM 2004;97:407-12.
    • (2004) QJM , vol.97 , pp. 407-412
    • Ferrari, R.1    Pappas, G.2    Agostinelli, D.3
  • 29
    • 79251513939 scopus 로고    scopus 로고
    • Autoimmune acute liver failure: Proposed clinical and histological criteria
    • Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune acute liver failure: Proposed clinical and histological criteria. Hepatology 2011;53:517-26.
    • (2011) Hepatology , vol.53 , pp. 517-526
    • Stravitz, R.T.1    Lefkowitch, J.H.2    Fontana, R.J.3
  • 30
    • 84866384808 scopus 로고    scopus 로고
    • Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation
    • Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci 2012;57:2248-66.
    • (2012) Dig Dis Sci , vol.57 , pp. 2248-2266
    • Czaja, A.J.1
  • 31
    • 0035153638 scopus 로고    scopus 로고
    • Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis
    • Abe M, Hiasa Y, Masumoto T, et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol Res 2001;21:213-9.
    • (2001) Hepatol Res , vol.21 , pp. 213-219
    • Abe, M.1    Hiasa, Y.2    Masumoto, T.3
  • 32
    • 58149197665 scopus 로고    scopus 로고
    • Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis
    • Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol 2008;43:951-8.
    • (2008) J Gastroenterol , vol.43 , pp. 951-958
    • Fujiwara, K.1    Fukuda, Y.2    Yokosuka, O.3
  • 33
    • 73149085031 scopus 로고    scopus 로고
    • Autoimmune hepatitis with acute presentation in Japan
    • Miyake Y, Iwasaki Y, Kobashi H, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis 2010;42:51-4.
    • (2010) Dig Liver Dis , vol.42 , pp. 51-54
    • Miyake, Y.1    Iwasaki, Y.2    Kobashi, H.3
  • 34
    • 79954414704 scopus 로고    scopus 로고
    • Clinicopathological features of severe and fulminant forms of autoimmune hepatitis
    • Yasui S, Fujiwara K, Yonemitsu Y, et al. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011;46:378-90.
    • (2011) J Gastroenterol , vol.46 , pp. 378-390
    • Yasui, S.1    Fujiwara, K.2    Yonemitsu, Y.3
  • 35
    • 33846805723 scopus 로고    scopus 로고
    • Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis
    • Abe M, Onji M, Kawai-Ninomiya K, et al. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol 2007;5:255-8.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 255-258
    • Abe, M.1    Onji, M.2    Kawai-Ninomiya, K.3
  • 36
    • 34547394251 scopus 로고    scopus 로고
    • Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis
    • Ichai P, Duclos-Vallee JC, Guettier C, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007;13:996-1003.
    • (2007) Liver Transpl , vol.13 , pp. 996-1003
    • Ichai, P.1    Duclos-Vallee, J.C.2    Guettier, C.3
  • 37
    • 0023812878 scopus 로고
    • Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis
    • Czaja AJ, Rakela J, Ludwig J. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 1988;95:448-53.
    • (1988) Gastroenterology , vol.95 , pp. 448-453
    • Czaja, A.J.1    Rakela, J.2    Ludwig, J.3
  • 38
    • 11844269814 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids
    • Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005;44:61-98.
    • (2005) Clin Pharmacokinet , vol.44 , pp. 61-98
    • Czock, D.1    Keller, F.2    Rasche, F.M.3    Haussler, U.4
  • 39
    • 84867492451 scopus 로고    scopus 로고
    • Drug choices in autoimmune hepatitis: Part A - Steroids
    • Czaja AJ. Drug choices in autoimmune hepatitis: Part A - steroids. Expert Rev Gastroenterol Hepatol 2012;6:603-15.
    • (2012) Expert Rev Gastroenterol Hepatol , vol.6 , pp. 603-615
    • Czaja, A.J.1
  • 40
    • 58049088632 scopus 로고    scopus 로고
    • Clinical epidemiology of fulminant hepatitis in Japan
    • Takikawa Y, Suzuki K. Clinical epidemiology of fulminant hepatitis in Japan. Hepatol Res 2008;38(Suppl 1):S14-8.
    • (2008) Hepatol Res , vol.38 , Issue.SUPPL. 1
    • Takikawa, Y.1    Suzuki, K.2
  • 41
    • 0042332240 scopus 로고    scopus 로고
    • Liver transplantation for autoimmune hepatitis: Fulminant versus chronic hepatitis presentation
    • Nunez-Martinez O, De la Cruz G, Salcedo M, et al. Liver transplantation for autoimmune hepatitis: Fulminant versus chronic hepatitis presentation. Transplant Proc 2003;35:1857-8.
    • (2003) Transplant Proc , vol.35 , pp. 1857-1858
    • Nunez-Martinez, O.1    De La Cruz, G.2    Salcedo, M.3
  • 42
    • 34547419539 scopus 로고    scopus 로고
    • Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: Therapeutic brinksmanship and the point beyond salvation
    • Czaja AJ. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: Therapeutic brinksmanship and the point beyond salvation. Liver Transpl 2007;13:953-5.
    • (2007) Liver Transpl , vol.13 , pp. 953-955
    • Czaja, A.J.1
  • 43
    • 59649086033 scopus 로고    scopus 로고
    • Features and consequences of untreated type 1 autoimmune hepatitis
    • Czaja AJ. Features and consequences of untreated type 1 autoimmune hepatitis. Liver Int 2009;29:816-23.
    • (2009) Liver Int , vol.29 , pp. 816-823
    • Czaja, A.J.1
  • 44
    • 0021246718 scopus 로고
    • Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: Morphologic spectrum, clinical correlations and terminology
    • Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: Morphologic spectrum, clinical correlations and terminology. Liver 1984;4:105-16.
    • (1984) Liver , vol.4 , pp. 105-116
    • Ludwig, J.1    Czaja, A.J.2    Dickson, E.R.3    Larusso, N.F.4    Wiesner, R.H.5
  • 45
    • 0034034595 scopus 로고    scopus 로고
    • Autoimmune cholangitis within the spectrum of autoimmune liver disease
    • Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 2000;31:1231-8.
    • (2000) Hepatology , vol.31 , pp. 1231-1238
    • Czaja, A.J.1    Carpenter, H.A.2    Santrach, P.J.3    Moore, S.B.4
  • 46
    • 0027146326 scopus 로고
    • Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis
    • Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-32.
    • (1993) Gastroenterology , vol.105 , pp. 1824-1832
    • Czaja, A.J.1    Carpenter, H.A.2
  • 47
    • 84876334054 scopus 로고    scopus 로고
    • The overlap syndromes of autoimmune hepatitis
    • Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci 2013;58:326-43.
    • (2013) Dig Dis Sci , vol.58 , pp. 326-343
    • Czaja, A.J.1
  • 48
    • 78751572618 scopus 로고    scopus 로고
    • Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue
    • Boberg KM, Chapman RW, Hirschfield GM, et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54:374-85.
    • (2011) J Hepatol , vol.54 , pp. 374-385
    • Boberg, K.M.1    Chapman, R.W.2    Hirschfield, G.M.3
  • 49
    • 77952711598 scopus 로고    scopus 로고
    • Practice guidelines of the American association for the study of liver diseases. Diagnosis and management of autoimmune hepatitis
    • Manns MP, Czaja AJ, Gorham JD, et al. Practice Guidelines of the American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-213.
    • (2010) Hepatology , vol.51 , pp. 2193-2213
    • Manns, M.P.1    Czaja, A.J.2    Gorham, J.D.3
  • 50
    • 0035117791 scopus 로고    scopus 로고
    • Duration of immunosuppressive therapy in autoimmune hepatitis
    • Kanzler S, Gerken G, Lohr H, et al. Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol 2001;34:354-5.
    • (2001) J Hepatol , vol.34 , pp. 354-355
    • Kanzler, S.1    Gerken, G.2    Lohr, H.3
  • 51
    • 67349145925 scopus 로고    scopus 로고
    • Rapidity of treatment response and outcome in type 1 autoimmune hepatitis
    • Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol 2009;51:161-7.
    • (2009) J Hepatol , vol.51 , pp. 161-167
    • Czaja, A.J.1
  • 52
    • 1642285767 scopus 로고    scopus 로고
    • Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
    • Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004;40:646-52.
    • (2004) J Hepatol , vol.40 , pp. 646-652
    • Czaja, A.J.1    Carpenter, H.A.2
  • 53
    • 0030065386 scopus 로고    scopus 로고
    • Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
    • Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996;110:848-57.
    • (1996) Gastroenterology , vol.110 , pp. 848-857
    • Roberts, S.K.1    Therneau, T.M.2    Czaja, A.J.3
  • 54
    • 0035002235 scopus 로고    scopus 로고
    • Long-term management and prognosis of autoimmune hepatitis (AIH): A single center experience
    • 44-8
    • Kanzler S, Lohr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): A single center experience. Z Gastroenterol 2001;39:339-41, 44-8.
    • (2001) Z Gastroenterol , vol.39 , pp. 339-341
    • Kanzler, S.1    Lohr, H.2    Gerken, G.3    Galle, P.R.4    Lohse, A.W.5
  • 55
    • 33748653157 scopus 로고    scopus 로고
    • Type i autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study
    • Floreani A, Niro G, Rosa Rizzotto E, et al. Type I autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 2006;24:1051-7.
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 1051-1057
    • Floreani, A.1    Niro, G.2    Rosa Rizzotto, E.3
  • 57
    • 79958162463 scopus 로고    scopus 로고
    • Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center
    • Hoeroldt B, McFarlane E, Dube A, et al. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center. Gastroenterology 2011;140:1980-9.
    • (2011) Gastroenterology , vol.140 , pp. 1980-1989
    • Hoeroldt, B.1    McFarlane, E.2    Dube, A.3
  • 58
    • 4444250848 scopus 로고    scopus 로고
    • Factors predicting relapse and poor outcome in type i autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy
    • Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004;99:1510-6.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1510-1516
    • Verma, S.1    Gunuwan, B.2    Mendler, M.3    Govindrajan, S.4    Redeker, A.5
  • 59
    • 27744580616 scopus 로고    scopus 로고
    • Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis
    • Miyake Y, Iwasaki Y, Terada R, et al. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis. J Hepatol 2005;43:951-7.
    • (2005) J Hepatol , vol.43 , pp. 951-957
    • Miyake, Y.1    Iwasaki, Y.2    Terada, R.3
  • 60
    • 34247860578 scopus 로고    scopus 로고
    • Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse
    • Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol 2007;102:1005-12.
    • (2007) Am J Gastroenterol , vol.102 , pp. 1005-1012
    • Montano-Loza, A.J.1    Carpenter, H.A.2    Czaja, A.J.3
  • 61
    • 54549127081 scopus 로고    scopus 로고
    • Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis
    • Luth S, Herkel J, Kanzler S, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol 2008;42:926-30.
    • (2008) J Clin Gastroenterol , vol.42 , pp. 926-930
    • Luth, S.1    Herkel, J.2    Kanzler, S.3
  • 62
    • 84866393237 scopus 로고    scopus 로고
    • Systematic review: Managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs
    • Selvarajah V, Montano-Loza AJ, Czaja AJ. Systematic review: Managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther 2012;36:691-707.
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 691-707
    • Selvarajah, V.1    Montano-Loza, A.J.2    Czaja, A.J.3
  • 63
    • 0036211577 scopus 로고    scopus 로고
    • Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysis
    • Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysis. Hepatology 2002;35:890-7.
    • (2002) Hepatology , vol.35 , pp. 890-897
    • Czaja, A.J.1    Menon, K.V.2    Carpenter, H.A.3
  • 64
    • 0029130857 scopus 로고
    • Azathioprine for long-term maintenance of remission in autoimmune hepatitis
    • Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-63.
    • (1995) N Engl J Med , vol.333 , pp. 958-963
    • Johnson, P.J.1    McFarlane, I.G.2    Williams, R.3
  • 65
    • 0025298505 scopus 로고
    • Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis
    • Czaja AJ. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis. Hepatology 1990;11:1044-9.
    • (1990) Hepatology , vol.11 , pp. 1044-1049
    • Czaja, A.J.1
  • 66
    • 22844437295 scopus 로고    scopus 로고
    • Autoimmune hepatitis type 1: Safety and efficacy of prolonged medical therapy
    • Seela S, Sheela H, Boyer JL. Autoimmune hepatitis type 1: Safety and efficacy of prolonged medical therapy. Liver Int 2005;25:734-9.
    • (2005) Liver Int , vol.25 , pp. 734-739
    • Seela, S.1    Sheela, H.2    Boyer, J.L.3
  • 67
    • 84871211618 scopus 로고    scopus 로고
    • Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission
    • van Gerven NM, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013;58:141-7.
    • (2013) J Hepatol , vol.58 , pp. 141-147
    • Van Gerven, N.M.1    Verwer, B.J.2    Witte, B.I.3
  • 68
    • 0021217938 scopus 로고
    • Complete resolution of inflammatory activity following corticosteroid treatment of HBsAgnegative chronic active hepatitis
    • Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAgnegative chronic active hepatitis. Hepatology 1984;4:622-7.
    • (1984) Hepatology , vol.4 , pp. 622-627
    • Czaja, A.J.1    Davis, G.L.2    Ludwig, J.3    Taswell, H.F.4
  • 69
    • 34047223229 scopus 로고    scopus 로고
    • Consequences of treatment withdrawal in type 1 autoimmune hepatitis
    • Montano-Loza AJ, Carpenter HA, Czaja AJ. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver Int 2007;27:507-15.
    • (2007) Liver Int , vol.27 , pp. 507-515
    • Montano-Loza, A.J.1    Carpenter, H.A.2    Czaja, A.J.3
  • 70
    • 36349017310 scopus 로고    scopus 로고
    • Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the Model of End-stage Liver Disease
    • Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the Model of End-stage Liver Disease. Hepatology 2007;46:1138-45.
    • (2007) Hepatology , vol.46 , pp. 1138-1145
    • Montano-Loza, A.J.1    Carpenter, H.A.2    Czaja, A.J.3
  • 71
    • 79952203791 scopus 로고    scopus 로고
    • Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis
    • Yeoman AD, Westbrook RH, Zen Y, et al. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology 2011;53:926-34.
    • (2011) Hepatology , vol.53 , pp. 926-934
    • Yeoman, A.D.1    Westbrook, R.H.2    Zen, Y.3
  • 72
    • 33645219865 scopus 로고    scopus 로고
    • Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly
    • Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006;43:532-8.
    • (2006) Hepatology , vol.43 , pp. 532-538
    • Czaja, A.J.1    Carpenter, H.A.2
  • 73
    • 77954423957 scopus 로고    scopus 로고
    • Autoantibodies as prognostic markers in autoimmune liver disease
    • Czaja AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci 2010;55:2144-61.
    • (2010) Dig Dis Sci , vol.55 , pp. 2144-2161
    • Czaja, A.J.1
  • 74
    • 83255170463 scopus 로고    scopus 로고
    • Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis
    • Montano-Loza AJ, Shums Z, Norman GL, Czaja AJ. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis. Liver Int 2012;32:85-92.
    • (2012) Liver Int , vol.32 , pp. 85-92
    • Montano-Loza, A.J.1    Shums, Z.2    Norman, G.L.3    Czaja, A.J.4
  • 75
    • 0031032711 scopus 로고    scopus 로고
    • Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis
    • Czaja AJ, Strettell MD, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997;25:317-23.
    • (1997) Hepatology , vol.25 , pp. 317-323
    • Czaja, A.J.1    Strettell, M.D.2    Thomson, L.J.3
  • 76
    • 0036174801 scopus 로고    scopus 로고
    • Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis
    • Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol 2002;97:413-9.
    • (2002) Am J Gastroenterol , vol.97 , pp. 413-419
    • Czaja, A.J.1    Donaldson, P.T.2    Lohse, A.W.3
  • 77
    • 84872168522 scopus 로고    scopus 로고
    • Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study
    • Efe C, Ozaslan E, Wahlin S, et al. Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study. Liver Int 2013;33:190-6.
    • (2013) Liver Int , vol.33 , pp. 190-196
    • Efe, C.1    Ozaslan, E.2    Wahlin, S.3
  • 78
    • 18244366619 scopus 로고    scopus 로고
    • Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease
    • Ma Y, Okamoto M, Thomas MG, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002;35:658-64.
    • (2002) Hepatology , vol.35 , pp. 658-664
    • Ma, Y.1    Okamoto, M.2    Thomas, M.G.3
  • 79
    • 0036070963 scopus 로고    scopus 로고
    • Establishment of standardised SLA/LP immunoassays: Specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics
    • Baeres M, Herkel J, Czaja AJ, et al. Establishment of standardised SLA/LP immunoassays: Specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002;51:259-64.
    • (2002) Gut , vol.51 , pp. 259-264
    • Baeres, M.1    Herkel, J.2    Czaja, A.J.3
  • 80
    • 2442481067 scopus 로고    scopus 로고
    • Alpha-actinin revisited: A fresh look at an old player
    • Otey CA, Carpen O. Alpha-actinin revisited: A fresh look at an old player. Cell Motil Cytoskeleton 2004;58:104-11.
    • (2004) Cell Motil Cytoskeleton , vol.58 , pp. 104-111
    • Otey, C.A.1    Carpen, O.2
  • 81
    • 33751120137 scopus 로고    scopus 로고
    • Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1
    • Gueguen P, Dalekos G, Nousbaum JB, et al. Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol 2006;26:495-505.
    • (2006) J Clin Immunol , vol.26 , pp. 495-505
    • Gueguen, P.1    Dalekos, G.2    Nousbaum, J.B.3
  • 82
    • 84867526442 scopus 로고    scopus 로고
    • Drug choices in autoimmune hepatitis: Part B - Nonsteroids
    • Czaja AJ. Drug choices in autoimmune hepatitis: Part B - nonsteroids. Expert Rev Gastroenterol Hepatol 2012;6:617-35.
    • (2012) Expert Rev Gastroenterol Hepatol , vol.6 , pp. 617-635
    • Czaja, A.J.1
  • 83
    • 37549041628 scopus 로고    scopus 로고
    • In utero exposure to mycophenolate mofetil: A characteristic phenotype?
    • Perez-Aytes A, Ledo A, Boso V, et al. In utero exposure to mycophenolate mofetil: A characteristic phenotype? Am J Med Genet A 2008;146A:1-7.
    • (2008) Am J Med Genet A , vol.146 , pp. 1-7
    • Perez-Aytes, A.1    Ledo, A.2    Boso, V.3
  • 84
    • 77957345684 scopus 로고    scopus 로고
    • Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis
    • Manns MP, Woynarowski M, Kreisel W, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010;139:1198-206.
    • (2010) Gastroenterology , vol.139 , pp. 1198-1206
    • Manns, M.P.1    Woynarowski, M.2    Kreisel, W.3
  • 85
    • 0034321507 scopus 로고    scopus 로고
    • Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
    • Czaja AJ, Lindor KD. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 2000;119:1312-6.
    • (2000) Gastroenterology , vol.119 , pp. 1312-1316
    • Czaja, A.J.1    Lindor, K.D.2
  • 86
    • 0347598081 scopus 로고    scopus 로고
    • Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: Influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC
    • Geier A, Gartung C, Dietrich CG, et al. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: Influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J Gastroenterol 2003;9:2681-5.
    • (2003) World J Gastroenterol , vol.9 , pp. 2681-2685
    • Geier, A.1    Gartung, C.2    Dietrich, C.G.3
  • 87
    • 80052435492 scopus 로고    scopus 로고
    • Budesonide for the treatment of autoimmune hepatitis
    • Snider KR, Potter TG. Budesonide for the treatment of autoimmune hepatitis. Ann Pharmacother 2011;45:1144-50.
    • (2011) Ann Pharmacother , vol.45 , pp. 1144-1150
    • Snider, K.R.1    Potter, T.G.2
  • 88
    • 77950327120 scopus 로고    scopus 로고
    • Rituximab in autoimmune hematologic diseases: Not just a matter of B cells
    • Stasi R. Rituximab in autoimmune hematologic diseases: Not just a matter of B cells. Semin Hematol 2010;47:170-9.
    • (2010) Semin Hematol , vol.47 , pp. 170-179
    • Stasi, R.1
  • 89
    • 84877603475 scopus 로고    scopus 로고
    • Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy
    • Burak KW, Swain MG, Santodomino-Garzon T, et al. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. Can J Gastroenterol 2013;27:273-80.
    • (2013) Can J Gastroenterol , vol.27 , pp. 273-280
    • Burak, K.W.1    Swain, M.G.2    Santodomino-Garzon, T.3
  • 90
    • 84873279968 scopus 로고    scopus 로고
    • Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis
    • Dhirapong A, Yang GX, Nadler S, et al. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 2013;57:708-15.
    • (2013) Hepatology , vol.57 , pp. 708-715
    • Dhirapong, A.1    Yang, G.X.2    Nadler, S.3
  • 91
    • 3442885909 scopus 로고    scopus 로고
    • Impairment of CD4(+) CD25(+) regulatory T-cells in autoimmune liver disease
    • Longhi MS, Ma Y, Bogdanos DP, et al. Impairment of CD4(+) CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004;41:31-7.
    • (2004) J Hepatol , vol.41 , pp. 31-37
    • Longhi, M.S.1    Ma, Y.2    Bogdanos, D.P.3
  • 92
    • 84862658266 scopus 로고    scopus 로고
    • FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
    • Peiseler M, Sebode M, Franke B, et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol 2012;57:125-32.
    • (2012) J Hepatol , vol.57 , pp. 125-132
    • Peiseler, M.1    Sebode, M.2    Franke, B.3
  • 93
    • 84872162712 scopus 로고    scopus 로고
    • Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance
    • Lapierre P, Beland K, Yang R, Alvarez F. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance. Hepatology 2013;57:217-27.
    • (2013) Hepatology , vol.57 , pp. 217-227
    • Lapierre, P.1    Beland, K.2    Yang, R.3    Alvarez, F.4
  • 94
    • 39549122228 scopus 로고    scopus 로고
    • Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis
    • Longhi MS, Meda F, Wang P, et al. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology 2008;47:581-91.
    • (2008) Hepatology , vol.47 , pp. 581-591
    • Longhi, M.S.1    Meda, F.2    Wang, P.3
  • 95
    • 79955980763 scopus 로고    scopus 로고
    • Natural killer T cells in health and disease
    • Wu L, Van Kaer L. Natural killer T cells in health and disease. Front Biosci (Schol Ed) 2011;3:236-51.
    • (2011) Front Biosci (Schol Ed) , vol.3 , pp. 236-251
    • Wu, L.1    Van Kaer, L.2
  • 96
    • 80052623696 scopus 로고    scopus 로고
    • Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice
    • Blumenfeld HJ, Tohn R, Haeryfar SM, et al. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 2011;166:121-33.
    • (2011) Clin Exp Immunol , vol.166 , pp. 121-133
    • Blumenfeld, H.J.1    Tohn, R.2    Haeryfar, S.M.3
  • 97
    • 84862246208 scopus 로고    scopus 로고
    • Brief treatment with iNKT cell ligand alpha-galactosylceramide confers a long-term protection against lupus
    • Yang JQ, Kim PJ, Singh RR. Brief treatment with iNKT cell ligand alpha-galactosylceramide confers a long-term protection against lupus. J Clin Immunol 2012;32:106-13.
    • (2012) J Clin Immunol , vol.32 , pp. 106-113
    • Yang, J.Q.1    Kim, P.J.2    Singh, R.R.3
  • 98
    • 79953785705 scopus 로고    scopus 로고
    • Activation of natural killer T cells by alpha-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis
    • Yoshiga Y, Goto D, Segawa S, et al. Activation of natural killer T cells by alpha-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis. Clin Exp Immunol 2011;164:236-47.
    • (2011) Clin Exp Immunol , vol.164 , pp. 236-247
    • Yoshiga, Y.1    Goto, D.2    Segawa, S.3
  • 99
    • 0035742546 scopus 로고    scopus 로고
    • S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes
    • Majano PL, Garcia-Monzon C, Garcia-Trevijano ER, et al. S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol 2001;35:692-9.
    • (2001) J Hepatol , vol.35 , pp. 692-699
    • Majano, P.L.1    Garcia-Monzon, C.2    Garcia-Trevijano, E.R.3
  • 100
    • 0344867846 scopus 로고    scopus 로고
    • S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial
    • Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999;30:1081-9.
    • (1999) J Hepatol , vol.30 , pp. 1081-1089
    • Mato, J.M.1    Camara, J.2    Fernandez De Paz, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.